Nordea Investment Management
JAZZ icon

Nordea Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nordea Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,211
Closed -$628K – 928
2024
Q1 		$628K Sell
5,211
-915
-15% -$112K ﹤0.01% 881
2023
Q4 		$744K Sell
6,126
-440
-7% -$54.9K ﹤0.01% 862
2023
Q3 		$858K Sell
6,566
-348
-5% -$46.4K ﹤0.01% 838
2023
Q2 		$859K Hold
6,914
– – ﹤0.01% 839
2023
Q1 		$1M Sell
6,914
-595
-8% -$88K ﹤0.01% 789
2022
Q4 		$1.19M Buy
7,509
+1,138
+18% +$167K ﹤0.01% 742
2022
Q3 		$858K Sell
6,371
-3,585
-36% -$545K ﹤0.01% 801
2022
Q2 		$1.56M Buy
9,956
+1,154
+13% +$178K ﹤0.01% 728
2022
Q1 		$1.39M Hold
8,802
– – ﹤0.01% 750
2021
Q4 		$1.14M Hold
8,802
– – ﹤0.01% 788
2021
Q3 		$1.15M Hold
8,802
– – ﹤0.01% 786
2021
Q2 		$1.56M Sell
8,802
-13,393
-60% -$2.32M ﹤0.01% 716
2021
Q1 		$3.69M Sell
22,195
-2,363
-10% -$389K 0.01% 624
2020
Q4 		$4.05M Hold
24,558
– – 0.01% 610
2020
Q3 		$3.47M Sell
24,558
-24,558
-50% -$3.04M 0.01% 583
2020
Q2 		$5.34M Buy
49,116
+20,831
+74% +$2.3M 0.01% 604
2020
Q1 		$2.83M Hold
28,285
– – 0.01% 582
2019
Q4 		$4.21M Hold
28,285
– – 0.01% 599
2019
Q3 		$3.6M Buy
28,285
+522
+2% +$70K 0.01% 631
2019
Q2 		$3.96M Sell
27,763
-15,600
-36% -$2.1M 0.01% 597
2019
Q1 		$6.2M Sell
43,363
-1,596
-4% -$208K 0.01% 487
2018
Q4 		$5.57M Buy
44,959
+3,400
+8% +$504K 0.01% 472
2018
Q3 		$6.99M Buy
+41,559
New +$7.15M 0.01% 469

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Nordea Investment Management's JAZZ Position: Q2 2024 in Review

Nordea Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 5,211 shares — an estimated $628K sold.

Nordea Investment Management first reported a position in JAZZ in Q3 2018 and held it in 23 quarters. The position peaked at $6.99M in Q3 2018. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Nordea Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Nordea Investment Management sold 5,211 Jazz Pharmaceuticals shares in Q2 2024, an estimated $628K.
  • Nordea Investment Management first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 23 quarters.
  • Nordea Investment Management's Jazz Pharmaceuticals position peaked at $6.99M in Q3 2018.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Nordea Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.